Immunometabolism in rheumatoid arthritis

References

• Koppenol WH, Bounds PL, Dang CV, et al. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325–337.
   PubMed Web of Science ®Google Scholar
• Palsson-McDermott EM, O'Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35:965–973.
   PubMed Web of Science ®Google Scholar
• Ghesquière B, Wong BW, Kuchnio A, et al. Metabolism of stromal and immune cells in health and disease. Nature. 2014;511:167–176.
   PubMed Web of Science ®Google Scholar
• Millet P, Vachharajani V, McPhail L, et al. GAPDH binding to TNF-αmRNA contributes to posttranscriptional repression in monocytes: a novel mechanism of communication between inflammation and metabolism. JI. 2016;196:2541–2551.
   Google Scholar
• Bustamante MF, Garcia-Carbonell R, Whisenant KD, et al. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19:110.
   PubMed Web of Science ®Google Scholar
• Young SP, Kapoor SR, Viant MR, et al. The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum. 2013;65:2015–2023.
   PubMed Web of Science ®Google Scholar
• Lauridsen MB, Bliddal H, Christensen R, et al. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. J Proteome Res. 2010;9:4545–4553.
   PubMed Web of Science ®Google Scholar
• Madsen RK, Lundstedt T, Gabrielsson J, et al. Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther. 2011;13:R19.
   PubMed Web of Science ®Google Scholar
• Yang XY, Zheng KD, Lin K, et al. Energy metabolism disorder as a contributing factor of rheumatoid arthritis: a comparative proteomic and metabolomic study. PLoS One. 2015;10:e0132695.
   PubMed Web of Science ®Google Scholar
• Zabek A, Swierkot J, Malak A, et al. Application of (1)H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis. J Pharm Biomed Anal. 2016;117:544–550.
   PubMed Web of Science ®Google Scholar
• Guo H, Niu X, Gu Y, et al. Differential amino acid, carbohydrate and lipid metabolism perpetuations involved in a subtype of rheumatoid arthritis with chinese medicine cold pattern. IJMS. 2016;17:e1757.
   Google Scholar
• Li J, Che N, Xu L, et al. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis. Clin Rheumatol. 2018;37:1493–1502.
   Web of Science ®Google Scholar
• Jin L, Alesi GN, Kang S, et al. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35:3619–3625.
   PubMed Web of Science ®Google Scholar
• Cooper EH, Barkhan P, Hale AJ, et al. Observations on the proliferation of human leucocytes cultured with phytohaemagglutinin. Br J Haematol. 1963;9:101–111.
   Web of Science ®Google Scholar
• Guppy M, Greiner E, Brand K, et al. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem. 1993;212:95–99.
   PubMedGoogle Scholar
• Frauwirth KA, Riley JL, Harris MH, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 2002;16:769–777.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Burmester GR, Brand MD, et al. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today. 2000;21:192–199.
   PubMedGoogle Scholar
• Krauss S, Brand MD, Buttgereit F, et al. Signaling takes a breath–new quantitative perspectives on bioenergetics and signal transduction. Immunity. 2001;15:497–502.
   PubMed Web of Science ®Google Scholar
• Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35:871–882.
   PubMed Web of Science ®Google Scholar
• Chang C-H, Curtis JD, Maggi LB, et al. Posttranscriptional control of t cell effector function by aerobic glycolysis. Cell. 2013;153:1239–1251.
   PubMed Web of Science ®Google Scholar
• Kolev M, Dimeloe S, Le Friec G, et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity. 2015;42:1033–1047.
   PubMed Web of Science ®Google Scholar
• Shi LZ, Wang R, Huang G, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367–1376.
   PubMed Web of Science ®Google Scholar
• Araujo L, Khim P, Mkhikian H, et al. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. Elife. 2017;6:e21330.
   Web of Science ®Google Scholar
• Berod L, Friedrich C, Nandan A, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014;20:1327–1333.
   PubMed Web of Science ®Google Scholar
• Michalek RD, Gerriets VA, Jacobs SR, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186:3299–3303.
   PubMed Web of Science ®Google Scholar
• Sundrud MS, Koralov SB, Feuerer M, et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science. 2009;324:1334–1338.
   PubMed Web of Science ®Google Scholar
• Everts B, Amiel E, Huang SC-C, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat Immunol. 2014;15:323–332.
   PubMed Web of Science ®Google Scholar
• Sim WJ, Ahl PJ, Connolly JE, et al. Metabolism is central to tolerogenic dendritic cell function. Mediators Mediators Inflamm. 2016;2016:1.
   Google Scholar
• Ferreira GB, Kleijwegt FS, Waelkens E, et al. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res. 2012;11:941–971.
   PubMed Web of Science ®Google Scholar
• Rhoads JP, Major AS, Rathmell JC, et al. Fine tuning of immunometabolism for the treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13:313–320.
   PubMed Web of Science ®Google Scholar
• Seki SM, Gaultier A. Exploring non-metabolic functions of glycolytic enzymes in immunity. Front Immunol. 2017;8:1549.
   Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345–1352.
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203:2673–2682
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul W. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010;28:445–489.
   PubMed Web of Science ®Google Scholar
• Wang W, Shao S, Jiao Z, et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int. 2012;32:887–893.
   PubMed Web of Science ®Google Scholar
• Yang Z, Fujii H, Mohan SV, et al. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med. 2013;210:2119–2134.
   PubMed Web of Science ®Google Scholar
• Sena LA, Li S, Jairaman A, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013;38:225–236.
   PubMed Web of Science ®Google Scholar
• Yang Z, Shen Y, Oishi H, et al. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med. 2016;8:331ra38.
   Web of Science ®Google Scholar
• Sun L, Fu J, Zhou Y, et al. Metabolism controls the balance of Th17/T-regulatory cells. Front Immunol. 2017;8:1632.
   PubMed Web of Science ®Google Scholar
• Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24–33.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Saegusa J, Sendo S, et al. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2017;19:76.
   Web of Science ®Google Scholar
• Henderson B, Bitensky L, Chayen J, et al. Glycolytic activity in human synovial lining cells in rheumatoid arthritis. Ann Rheum Dis. 1979;38:63–67.
   PubMedGoogle Scholar
• Ahn JK, Kim S, Hwang J, et al. Metabolomic elucidation of the effects of curcumin on fibroblast-like synoviocytes in rheumatoid arthritis. PLoS One. 2015;10:e0145539.
   PubMed Web of Science ®Google Scholar
• Ahn JK, Kim S, Hwang J, et al. GC/TOF-MS-based metabolomic profiling in cultured fibroblast-like synoviocytes from rheumatoid arthritis. Joint Bone Spine. 2016;83:707–713.
   Web of Science ®Google Scholar
• Okano T, Saegusa J, Nishimura K, et al. 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation. Sci Rep. 2017;10:42412.
   Google Scholar
• Panneton V, Bagherzadeh Yazdchi S, Witalis M, et al. ICOS signaling controls induction and maintenance of collagen-induced arthritis. J Immunol. 2018;200:3067–3076.
   Web of Science ®Google Scholar
• Bian L, Josefsson E, Jonsson I-M, et al. Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther. 2009;11:R132.
   PubMed Web of Science ®Google Scholar
• Garcia-Carbonell R, Divakaruni AS, Lodi A, et al. Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2016;68:1614–1626.
   PubMed Web of Science ®Google Scholar
• Fox CJ, Hammerman PS, Thompson CB, et al. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol. 2005;5:844–852.
   PubMed Web of Science ®Google Scholar
• Lai R, Xian D, Xiong X, et al. Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells. Redox Rep. 2018;23:130–135.
   PubMed Web of Science ®Google Scholar
• Essig K, Hu D, Guimaraes JC, et al. Roquin suppresses the PI3K-mTOR signaling pathway to inhibit T helper cell differentiation and conversion of Treg to Tfr Cells. Immunity. 2017;47:1067–1082;e12.
   Web of Science ®Google Scholar
• Binger KJ, et al. Immunometabolic regulation of interleukin-17-producing T helper cells: uncoupling new targets for autoimmunity. Front Immunol. 2017;8:311.
   Google Scholar
• Ma H, Botstein D. Effects of null mutations in the hexokinase genes of Saccharomyces cerevisiae on catabolite repression. Mol Cell Biol. 1986;6:4046–4052.
   PubMed Web of Science ®Google Scholar
• Moreno F, Herrero P. The hexokinase 2-dependent glucose signal transduction pathway of Saccharomyces cerevisiae. FEMS Microbiol Rev. 2002;26:83–90.
   Web of Science ®Google Scholar
• Ahuatzi D, Herrero P, de la Cera T, et al. The glucose-regulated nuclear localization of hexokinase 2 in Saccharomyces cerevisiae is Mig1-dependent. J Biol Chem. 2004;279:14440–14446.
   PubMed Web of Science ®Google Scholar
• Saad S, Peter M, Dechant R, et al. In scarcity and abundance: metabolic signals regulating cell growth. Physiology (Bethesda)). 2013;28:298–309.
   Web of Science ®Google Scholar
• Lv L, Xu Y-P, Zhao D, et al. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol Cell. 2013;52:340–352.
   PubMed Web of Science ®Google Scholar
• Shirai T, Nazarewicz RR, Wallis BB, et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med. 2016;213:337–354.
   Web of Science ®Google Scholar
• Luo W, Hu H, Chang R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732–744.
   PubMed Web of Science ®Google Scholar
• Gao X, Wang H, Yang JJ, et al. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell. 2012;45:598–609.
   PubMed Web of Science ®Google Scholar
• Demaria M, Poli V. PKM2, STAT3 and HIF-1α: The Warburg's vicious circle. JAKSTAT. 2012;1:194–196.
   PubMedGoogle Scholar
• Feo S, Arcuri D, Piddini E, et al. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 2000;473:47–52.
   PubMed Web of Science ®Google Scholar
• Ray R, Miller DM. Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol. 1991;11:2154–2161.
   PubMed Web of Science ®Google Scholar
• De Rosa V, Galgani M, Porcellini A, et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat Immunol. 2015;16:1174–1184.
   PubMed Web of Science ®Google Scholar
• Du J, Huang C, Zhou B, et al. Isoform-specific inhibition of ROR α-mediated transcriptional activation by human FOXP3. J Immunol. 2008;180:4785–4792.
   PubMed Web of Science ®Google Scholar
• Peng M, Yin N, Chhangawala S, et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354:481–484.
   PubMed Web of Science ®Google Scholar
• Pioli PA, Hamilton BJ, Connolly JE, et al. Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1. J Biol Chem. 2002;277:35738–35745.
   PubMed Web of Science ®Google Scholar